Thiogenesis Therapeutics, Corp. (TSXV:TTI)
Canada
· Delayed Price · Currency is CAD 0.530
+0.010 (1.92%)
At close: Apr 28, 2026
Thiogenesis Therapeutics Market Cap
Thiogenesis Therapeutics has a market cap or net worth of CAD 27.47 million as of April 28, 2026. Its market cap has decreased by -9.54% in one year.
Market Cap
27.47M
Enterprise Value
23.97M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.53
Market Cap Chart
Since April 13, 2022, Thiogenesis Therapeutics's market cap has increased from 13.96M to 27.47M, an increase of 96.87%. That is a compound annual growth rate of 18.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 27.47M | -18.46% |
| Dec 31, 2025 | 33.69M | 22.03% |
| Dec 31, 2024 | 27.61M | -17.40% |
| Dec 29, 2023 | 33.43M | 48.30% |
| Dec 30, 2022 | 22.54M | 61.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quantum BioPharma | 28.85M |
| Resverlogix | 31.62M |
| Devonian Health Group | 33.09M |
| Microbix Biosystems | 33.82M |
| Lobe Sciences | 36.93M |
| Telescope Innovations | 37.98M |
| BriaCell Therapeutics | 38.43M |
| MedMira | 42.10M |